G Luporini

1.9k total citations
48 papers, 1.5k citations indexed

About

G Luporini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G Luporini has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in G Luporini's work include Colorectal Cancer Treatments and Studies (19 papers), Gastric Cancer Management and Outcomes (14 papers) and Cancer Treatment and Pharmacology (8 papers). G Luporini is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Gastric Cancer Management and Outcomes (14 papers) and Cancer Treatment and Pharmacology (8 papers). G Luporini collaborates with scholars based in Italy, Switzerland and Germany. G Luporini's co-authors include Roberto Labianca, Sandro Barni, M. Clerici, Paolo Fraschini, Gianni Beretta, M Pirovano, M. De Lena, Cristina Oliva, Dino Amadori and Michael Pacini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

G Luporini

47 papers receiving 1.4k citations

Peers

G Luporini
Masakazu Ikenaga Japan
G. Lennard Gold United States
William Pfaff United States
Nicolas Janus France
G Buccheri Italy
Menahem Ben‐Haim Israel
C. Mertens France
Steven Oliver United Kingdom
Ioannis Kaklamanos Greece
Dorin Colibaseanu United States
Masakazu Ikenaga Japan
G Luporini
Citations per year, relative to G Luporini G Luporini (= 1×) peers Masakazu Ikenaga

Countries citing papers authored by G Luporini

Since Specialization
Citations

This map shows the geographic impact of G Luporini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Luporini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Luporini more than expected).

Fields of papers citing papers by G Luporini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Luporini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Luporini. The network helps show where G Luporini may publish in the future.

Co-authorship network of co-authors of G Luporini

This figure shows the co-authorship network connecting the top 25 collaborators of G Luporini. A scholar is included among the top collaborators of G Luporini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Luporini. G Luporini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cascinu, Stefano, Sandro Barni, Roberto Labianca, et al.. (1999). A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 80(10). 1595–1598. 68 indexed citations
2.
Pirovano, M, Marco Maltoni, Oriana Nanni, et al.. (1999). A New Palliative Prognostic Score. Journal of Pain and Symptom Management. 17(4). 231–239. 340 indexed citations
3.
Pizzocaro, Giorgio, Luigi Piva, Franco Lombardi, et al.. (1999). Subcutaneous Administration of Interleukin-2 and Interferon-alpha2b in Advanced Renal Cell Carcinoma: Long-Term Results. Cancer Detection and Prevention. 23(2). 172–176. 5 indexed citations
4.
Luporini, G, et al.. (1998). Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. European Respiratory Journal. 12(1). 97–101. 47 indexed citations
5.
Lorusso, Vito, C. F. Pollera, Mauro Antimi, et al.. (1998). A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. European Journal of Cancer. 34(8). 1208–1212. 242 indexed citations
6.
7.
Gs, Del Giacco & G Luporini. (1998). [Observations on a case of beta-2A-paraproteinemia].. PubMed. 41. 138–43.
8.
9.
Cascinu, Stefano, Sandro Barni, Roberto Labianca, et al.. (1997). Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. Supportive Care in Cancer. 5(4). 314–317. 24 indexed citations
10.
Tedeschi, L., et al.. (1996). Cisplatin-associated anaemia in patients with solid tumours. Supportive Care in Cancer. 4(3). 218–219. 4 indexed citations
11.
Labianca, Roberto, G. Pancera, & G Luporini. (1996). Factors influencing response rates for advanced colorectal cancer chemotherapy. Annals of Oncology. 7(9). 901–906. 8 indexed citations
12.
Bruzzone, Marco, Loredana Miglietta, D. Amoroso, et al.. (1996). Salvage Chemotherapy with Paclitaxel in Platinum-Resistant Advanced Ovarian Cancer Patients. Oncology. 53(5). 349–353. 7 indexed citations
13.
Zaniboni, Alberto, Roberto Labianca, G. Martignoni, et al.. (1996). Sequential Methotrexate and 5-Fluorouracil as Second-Line Chemotherapy for Advanced Colorectal Cancer Patients Pretreated with 5-Fluorouracil and Leucovorin: a GISCAD Study. Journal of Chemotherapy. 8(1). 82–84. 6 indexed citations
14.
Pizzocaro, Giorgio, Luigi Piva, Massimo Meregalli, et al.. (1995). Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study. British Journal of Cancer. 72(6). 1531–1535. 16 indexed citations
15.
16.
Labianca, Roberto, Sandro Barni, G. Ambrosini, et al.. (1994). Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience. European Journal of Cancer. 30(11). 1611–1616. 8 indexed citations
17.
Clerici, M., Valter Torri, Fulvia Colombo, et al.. (1994). Patterns of Care and Survival in Non Small Cell Lung Cancer: 15 Years’ Experience in a General Hospital. Tumori Journal. 80(2). 106–112. 7 indexed citations
18.
Cesana, Bruno Mario, et al.. (1993). A Cisplatinum- Cyclophosphamide Regimen in Advanced Ovarian Cancer: Reporting 5-Year Results. Oncology. 50(2). 92–99. 1 indexed citations
19.
Luporini, G, et al.. (1993). Medical treatment of hepatocellular carcinoma. Journal of Surgical Oncology. 53(S3). 115–118. 12 indexed citations
20.
Fraschini, Paolo, et al.. (1983). Confirmed activity of FAM polychemotherapy in advanced gastric carcinoma.. PubMed. 69(1). 59–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masakazu Ikenaga Breakdown of academic impact, for papers by G. Lennard Gold Breakdown of academic impact, for papers by William Pfaff Breakdown of academic impact, for papers by Nicolas Janus Breakdown of academic impact, for papers by G Buccheri Breakdown of academic impact, for papers by Menahem Ben‐Haim Breakdown of academic impact, for papers by C. Mertens Breakdown of academic impact, for papers by Steven Oliver Breakdown of academic impact, for papers by Ioannis Kaklamanos Breakdown of academic impact, for papers by Dorin Colibaseanu
Rankless by CCL
2026